Showing posts with label Pharmaceuticals. Show all posts
Showing posts with label Pharmaceuticals. Show all posts

Thursday, February 23, 2017

Europe Herbal Medicine Market Report 2017




Report Description:
This report studies sales (consumption) of Herbal Medicine in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Tsumura
Schwabe
Madaus
Weleda
Blackmores
Arkopharma
SIDO MUNCUL

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Herbal Medicine in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux

Table Of Contents:

Europe Herbal Medicine Market Report 2017
1 Herbal Medicine Overview
2 Europe Herbal Medicine by Manufacturers, Type and Application
3 Germany Herbal Medicine (Volume, Value and Sales Price)
4 France Herbal Medicine (Volume, Value and Sales Price)
5 UK Herbal Medicine (Volume, Value and Sales Price)
6 Russia Herbal Medicine (Volume, Value and Sales Price)


Wednesday, February 15, 2017

Nuclear Medicine/Radiopharmaceuticals Market - Global Forecasts to 2021




Report Description:

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the years, the nuclear medicine/radiopharmaceuticals market has witnessed various advancements in radiopharmaceuticals. The market is in its growth phase with an increasing number of radioisotope approvals for different clinical indications. Ra-223, I-131, and Y-90 ensured their leading position in the nuclear medicine therapeutic market.

Reasons to Buy the Report:
 
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps firms to garner a greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

Table Of Contents:

1 INTRODUCTION 15

2 RESEARCH METHODOLOGY 19

3 EXECUTIVE SUMMARY 28

 4 PREMIUM INSIGHTS 33

5 MARKET OVERVIEW 36

6 INDUSTRY TRENDS 46


Saturday, February 4, 2017

Global HIV Drugs Sales Market Report 2017


Report Description:

This report studies sales (consumption) of HIV Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Bristol-Myers Squibb
Gilead Sciences
GSK
Johnson
Merck
AbbVie
AstraZeneca
Boehringer Ingelheim
Cipla
Daiichi Sankyo
Emcure

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of HIV Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia

Table Of Contents:

Global HIV Drugs Sales Market Report 2017

1 HIV Drugs Overview
1.1 Product Overview and Scope of HIV Drugs
1.2 Classification of HIV Drugs
1.3 Application of HIV Drugs
1.4 HIV Drugs Market by Regions
1.5 Global Market Size (Value and Volume) of HIV Drugs (2012-2022)

2 Global HIV Drugs Competition by Manufacturers, Type and Application
2.1 Global HIV Drugs Market Competition by Manufacturers
2.2 Global HIV Drugs (Volume and Value) by Type
2.3 Global HIV Drugs (Volume and Value) by Regions
2.4 Global HIV Drugs (Volume) by Application

For more details VISIT @ https://www.grandresearchstore.com/pharmaceuticals/global-hiv-drugs-sales-market-report-20175Cr